Sophie contributed to the paper “Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation“, published in PLoS One. As she puts it: “This is a deeper dive into the infant TB cases diagnosed with Xpert. Almost all were diagnosed using non-sputum samples and 5% were rif resistant. We also observed an 11% mortality in TB cases. This is certainly the largest cohort of infant TB I’ve come across and it paints a scary picture!”
